Treatment and diagnostics lymphocytic leukemia in Dusseldorf, Germany

Lymphocytic leukemia is a combined hemoblastic and lymphoproliferative disease characterized by active reproduction and division of atypical lymphatic cells, leading to the accumulation of immature white blood cells in the blood. The disease occurs in people of different ages, and its prognosis depends on the stage at which it is detected, the patient’s general health, the causes of the oncological process, and a number of other factors. Treatment of lymphocytic leukemia in Dusseldorf is carried out by leading oncologists who know how to address both the cause and the consequences of the disease.

The following procedures are used to differentiate lymphocytic leukemia in Dusseldorf:

• laboratory blood studies,
• tumor marker tests,
• MRI, MSCT, and PET-CT of internal organs,
• ultrasound of the spleen,
• bone marrow biopsy with histological and cytological analysis.

After establishing the diagnosis, physicians hold a case conference and decide on the planned treatment.

The therapeutic regimen may include the following procedures:

• polychemotherapy or monochemotherapy,
• high-dose chemotherapy,
• allogeneic or autologous bone marrow transplant,
• radiation therapy on a linear accelerator with modulated beam intensity,
• therapy with monoclonal antibodies,
• biotherapy and immunotherapy,
• robot-assisted splenectomy.

Patients who have completed treatment are recommended a rehabilitation program. Its goal is to consolidate the therapeutic effect, prevent relapses, and improve overall health. Doctors in clinics in Dusseldorf do everything possible to bring the patient into stable remission for many years, improve quality of life, and protect against complications of the oncological disease.